There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and seven have been approved for emergency or full use in parts of Europe, North America, and Asia. In the United States, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Join NJ ACTS BERD on 1/22 for a Workshop with Dr. Yan Sun from NJIT
- How NJIT Graduate Student Jaimee Diogo Is Transforming STEM Futures Through ‘STEM Like a Girl’
- New Study Reveals Progress in Hospital Maternity Care Access in New Jersey, with Opportunities for Continued Improvement.
- Submit Your Proposal for Clinical Trials Days 2026
- New technology helps Rutgers Cancer Institute, RWJUH clinicians detect lung cancer sooner.
Categories
- Community (2,424)
- Covid (994)
- CTO Events (6)
- News (3,070)
- Pilots (21)